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Abstract
Background: The length of the huntingtin (HTT) CAG repeat is strongly correlated with both age at onset of Huntington’s
disease (HD) symptoms and age at death of HD patients. Dichotomous analysis comparing HD to controls is widely used to
study the effects of HTT CAG repeat expansion. However, a potentially more powerful approach is a continuous analysis
strategy that takes advantage of all of the different CAG lengths, to capture effects that are expected to be critical to HD
pathogenesis.
Methodology/Principal Findings: We used continuous and dichotomous approaches to analyze microarray gene
expression data from 107 human control and HD lymphoblastoid cell lines. Of all probes found to be significant in a
continuous analysis by CAG length, only 21.4% were so identified by a dichotomous comparison of HD versus controls.
Moreover, of probes significant by dichotomous analysis, only 33.2% were also significant in the continuous analysis.
Simulations revealed that the dichotomous approach would require substantially more than 107 samples to either detect
80% of the CAG-length correlated changes revealed by continuous analysis or to reduce the rate of significant differences
that are not CAG length-correlated to 20% (n = 133 or n = 206, respectively). Given the superior power of the continuous
approach, we calculated the correlation structure between HTT CAG repeat lengths and gene expression levels and created
a freely available searchable website, ‘‘HD CAGnome,’’ that allows users to examine continuous relationships between HTT
CAG and expression levels of ,20,000 human genes.
Conclusions/Significance: Our results reveal limitations of dichotomous approaches compared to the power of continuous
analysis to study a disease where human genotype-phenotype relationships strongly support a role for a continuum of CAG
length-dependent changes. The compendium of HTT CAG length-gene expression level relationships found at the HD
CAGnome now provides convenient routes for discovery of candidates influenced by the HD mutation.
Citation: Galkina EI, Shin A, Coser KR, Shioda T, Kohane IS, et al. (2014) HD CAGnome: A Search Tool for Huntingtin CAG Repeat Length-Correlated Genes. PLoS
ONE 9(4): e95556. doi:10.1371/journal.pone.0095556
Editor: David R. Borchelt, University of Florida, United States of America
Received December 20, 2013; Accepted March 28, 2014; Published April 21, 2014
Copyright:  2014 Galkina et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from CHDI Foundation, Inc. and theNational Institutes of Health (NS16367, NINDS Massachusetts HD Center
Without Walls (J.F.G.& M.E.M.), NS32765 (M.E.M.), NS049206 (V.C.W.), and LM008748 NLM i2b2 (I.S.K.)). The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jlee51@mgh.harvard.edu
. These authors contributed equally to this work.
Introduction
Huntington’s disease (HD, OMIM # 143100) is an autosomal
dominant neurodegenerative disorder caused by an expansion of a
polymorphic CAG trinucleotide repeat in the first exon of
huntingtin (HTT), the gene encoding huntingtin protein [1].
There is a strong inverse correlation of both age at onset of motor
symptoms and age at death with the HTT CAG repeat length in
HD subjects [1,2,3,4,5,6]. This continuous correlative relationship
strongly supports a role for dominant CAG length-dependent
mechanisms in determining the rate of disease processes that result
in manifestation of neurological symptoms. In addition, the
continuous relationships between HTT CAG repeat lengths and
molecular energy phenotypes also extend across the range of
expanded disease alleles and into the normal HTT CAG repeat
range (CAG,36), in a panel of blood-derived lymphoblastoid cell
lines [7]. These suggested that the HTT CAG repeat is a
functional polymorphism directly associated with an alteration of
huntingtin function that leads eventually to disease phenotypes.
These and other genotype-related phenotypes are also observed in
induced pluripotent stem cell derived neuronal cell lines [8]. Thus,
identifying biological processes that are influenced by the HTT
CAG repeat in a length-dependent manner will significantly
inform the molecular mechanisms underlying HD, and thereby,
facilitate the development of effective treatments.
As a part of our ongoing efforts to comprehensively optimize the
discovery of HTT CAG repeat length-dependent molecular
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changes, we undertook a global and unbiased approach to identify
genes whose expression levels were continuously correlated with
HTT CAG repeat lengths. We chose to study a panel of 107
human lymphoblastoid cell lines derived from HD subjects and
normal controls, as there are currently many more such lines
available than any other standardized cell types, making it possible
to include samples to achieve a broad and continuous spectrum of
CAG lengths. Although the effects of the HTT CAG repeat on
gene expression in lymphoblastoid cells were relatively modest, a
significant amount of variance in gene expression was attributable
to the HTT CAG repeat length [9]. These findings indicated that:
1) HTT CAG repeat length-correlated gene expression changes
exist, and 2) continuous analysis was able to identify HTT CAG
repeat length-dependent molecular signals from other factors
contributing noise, including genetic heterogeneity of the study
subjects, thereby demonstrating the power of continuous analytical
strategies. In addition, continuous analysis was able to detect
modest but significant correlations between HTT CAG repeat
lengths and genes that were not significant in a dichotomous
analytical comparison, supporting the sensitivity of continuous
analysis approaches. Taken together, these results demonstrated
the power of continuous analysis strategies to capture HTT CAG
length-correlated gene-expression signatures that conform to the
criteria expected for effects of the mechanism that contribute to
the HD disease process.
Despite their relevance to HD, continuous analysis approaches
are not widely used in the HD field. Instead, dichotomous analysis
methods comparing HD to normal controls are more widespread.
We hypothesize that dichotomous analysis methods are not
optimal for investigating HD where HTT CAG repeat length-
correlated alterations are strongly implicated in playing an
important role in HD pathogenesis. Thus, we performed a
continuous analysis and a dichotomous analysis on the same data
set comprising microarray gene expression data of 107 human
lymphoblastoid cell lines derived from HD and normal controls.
We then compared the results to evaluate the sensitivity and
specificity of the dichotomous analysis method, relative to the
continuous method based upon CAG length. In addition, based
upon those results, we created a searchable internet website, HD
CAGnome, where users can evaluate the relationships between




Gene expression profile data were generated from 107 Epstein–
Barr virus-transformed human lymphoblastoid cell lines, which
were maintained internally at the Massachusetts General Hospital.
These cell lines were derived from 105 independent subjects,
comprising 41 normal control samples (CAG,36) and 66 HD
samples (CAG.35) [9]. The mean sizes of the longer and shorter
alleles were 40.9 and 17.6 CAGs, respectively. The range of the
longer alleles was 15–92. Cells were grown in RPMI-1640 media
supplemented with 10% fetal bovine serum, 100 I.U./ml Penicil-
lin, and 100 I.U./ml Streptomycin at 37uC. The HTT CAG
repeat allele lengths for each sample were determined by a
polymerase chain reaction assay, against sequenced allele size
standards, as described previously [10]. For all analyses, only the
longer CAG allele was utilized, as the shorter allele has been
demonstrated not to contribute to HD age at onset [4]. For
microarray gene expression profiling experiments, total RNA was
extracted using TRIzol reagent (Invitrogen) and further purified
using a RNeasy kit (Qiagen). All RNA samples passed quality
control by 260/280 ratio (NanoDrop) and 28S/18S ratio (Agilent
Bioanalyzer assay). Total RNA (5 mg) was converted into cDNA
using SuperScript II reverse transcriptase (Invitrogen) and labeled
probe was synthesized by Single-Round RNA Amplification and
Biotin Labeling System (Enzo). Labeled probe (25 mg) was
hybridized to Affymetrix U133+2 arrays as recommended by the
manufacturer. All microarray data were processed together for
background correction and normalization using gcRMA (R,
2.11.1; gcrma, 2.20.0) followed by batch effect correction [11].
Statistical Analysis
We analyzed microarray expression data using two different
approaches. For the continuous analysis approach, we performed
1) a Pearson’s correlation test and 2) a Spearman’s rank
correlation test to evaluate the strength and significance of the
continuous relationship between CAG repeat length and expres-
sion level of a given gene. Based on dominance in HD, we
primarily used the length of longer CAG repeat in a given subject
to calculate the strength of correlation with gene expression levels.
In addition, due to the fact that the longer CAG repeat is highly
correlated with the sum of two CAGs in our samples, we observed
a high degree of similarity between two sets of correlation
coefficients based on 1) the longer CAG or 2) the sum of CAGs.
Therefore, we presented the results using the longer CAG repeat.
The continuous analysis results are presented in a scatter plot and
summary statistics of correlation tests in the HD CAGnome
website. For the dichotomous analysis approach, we performed a
Student’s t-test, comparing HD (66 samples; CAG.35) to normal
controls (41 samples, CAG,36) to determine whether the
expression level of a gene in HD differs significantly from that in
normal controls. Similarly, a box plot and a summary statistics
table are presented in the HD CAGnome website. All computa-
tional and statistical analyses were performed using R (version
2.11.1).
Comparison of Continuous Analysis Results to those of
Dichotomous Analysis
In order to estimate from dichotomous analysis 1) what
percentage of CAG-length correlated probes were detected and
2) what percentage of probes predicted as significant were in fact
not CAG-length correlated, we randomly selected variable
numbers of HD and normal samples from our dataset and
calculated the significance level of each probe using Student’s t-
test. These procedures were repeated 1,000 times for each sample
size analysis. We varied the sample size from 3 to 41; for example,
the first set of comparisons compared 3 randomly selected HD
samples to 3 randomly selected normal samples (n = 3), the second
set of comparisons compared 4 randomly selected HD samples to
4 randomly selected normal samples (n = 4), and so on. Since our
dataset had 41 normal control samples but 66 HD samples, we
compared up to 41 HD and 41 normal samples (n = 41). In each
iteration, p-values of nominally significant probes were recorded
and compared to p-values of the same probes obtained from
continuous analysis by CAG length of all samples using the
Pearson’s correlation test. We calculated 1) the fraction of all
probes significant in the continuous analysis that were also
significant by dichotomous analysis (i.e., continuous dichotomous
shared), 2) the fraction of all probes significant in the continuous
analysis that were not significant by dichotomous analysis (i.e.,
continuous specific), and 3) the fraction of all probes significant in
the dichotomous analysis that were not significant in the
continuous analysis (i.e., dichotomous specific). Based on these
results, statistical models were constructed in order to understand
relationships between parameters and to predict the sample sizes
HD CAGnome
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that allow dichotomous analysis to detect 80% of the positives
from continuous analysis and to reduce the rate of predicting
differences that are not significant in the continuous analysis to
20%. Although relationships may not be linear, linear models were
used because parametric models provide convenient tools for
extrapolation, and linear models generated model fits with high R-
squared values.
Website Construction
For each gene, the gene name, official HUGO symbol, and
Affymetrix probe set ID are dynamically generated via Perl CGI
scripts and presented. Pre-computed summary statistics and plots
are presented upon user’s input and selection. All raw data and
normalized data are available at Gene Expression Omnibus
(GSE34721). In addition, normalized data with summary statistics
are available for download from HD CAGnome.
Results
We performed continuous analysis and dichotomous analysis,
respectively, to identify genes whose expression levels were
correlated with HTT CAG repeat length (Pearson’s correlation
test) or whose expression levels were significantly different between
HD (CAG.35) and controls (CAG,36) (Student’s t-test). Figure 1
summarizes characteristics of overall test statistics from continuous
analysis (Fig. 1A and 1B) and dichotomous analysis (Fig. 1C and
1D). The range of Pearson’s correlation coefficients in the
continuous analysis was 20.431 to 0.396 (Fig. 1A), and the p-
value of the most significantly correlated probe was 0.00000358
(Fig. 1B). In the dichotomous analysis, the range of fold-change
was 22.33 to 2.39 (Fig. 1C), and the most significant p-value was
0.0000536 (Fig. 1D). Comparison of observed p-values to expected
p-values based on the uniform distribution revealed that the
overall test statistics were not inflated in either the continuous
analysis (Fig. 2A) or the dichotomous analysis (Fig. 2B). Compar-
ison of Pearson’s correlation coefficients in the continuous analysis
to fold-changes in the dichotomous analysis showed that 77% of
microarray probes showed the same direction of change (Fig. 3A;
top-right and bottom-left quadrants), and 23% of microarray
probes showed an opposite direction of change (Fig. 3A; top-left
and bottom-right quadrants). In addition, significance levels for
probes in the continuous analysis showed a modest correlation
with those in the dichotomous analysis (Fig. 3B), suggesting overall
similarity between the continuous analysis results and the
dichotomous analysis results.
Next, we compared significant probes. Nominal p-value of 0.01
was used to identify significant genes in each analysis. 718
microarray probes were significantly correlated with HTT CAG
repeat length in the continuous analysis (315 probes with positive
correlation and 403 probes with negative correlation). 464 probes
were significant in the dichotomous analysis (175 increase in HD
and 289 decrease in HD). Between significant probes in
continuous analysis and those in dichotomous analysis, 154 probes
were shared as shown in Fig. 4A. Probes significant in both
analyses showed consistent direction of change (Fig. 4B). For
example, 52 probes that showed nominally significant positive
correlation with HTT CAG repeat length were significantly
increased in HD compared to normal controls; 102 probes that
were negatively correlated with HTT CAG repeat length also
showed decreased expression levels in HD (Fig. 4B). Considering
that truly correlated genes must necessarily show differences in
dichotomous analysis, these observations indicate that statistics
from correlation analysis and dichotomous analysis for commonly
significant genes were not significantly affected by a subset of
influential data points.
Next, we evaluated potential limitations of the dichotomous
analysis strategy in HD where the importance of continuous
changes is strongly supported by human genotype-phenotype
relationships. We calculated two metrics of dichotomous analysis:
1) the percentage of the probes significant in continuous CAG-
length analysis that were also significant in dichotomous analysis,
21.4% (and by subtraction, the percentage not detected) and 2) the
percentage of probes that were significant in the dichotomous
analysis but not in the continuous analysis, 66.8%. Thus, the
dichotomous analysis failed to identify 78.6% of the significant
differences detected by continuous analysis, and only 33.2% of the
genes detected by dichotomous analysis actually showed significant
correlation with CAG length.
We predicted that dichotomous analysis may show even poorer
performance when the sample size is small. To test this prediction,
we performed simulation experiments employing dichotomous
analyses on variable numbers of randomly selected samples, and
determined the effect of sample size on the above metrics. For
each random sampling, we performed dichotomous analysis
utilizing Student’s t-test and calculated the metrics by comparing
to the results of all sample correlation analysis. For each sample
size, starting with n= 3 (i.e., 3 HD vs. 3 controls) and ending with
n= 41 (i.e., 41 HD vs. 41 controls), the dichotomous analysis and
comparison to the all sample continuous analysis were repeated
1,000 times. Figure 5 shows variation in the two metrics with
sample size, where the frequency of the percentages is represented
as smoothed color density in which darker color represents higher
frequency. For a given sample size, the outcomes were quite
variable, but there was a clear trend for increased sample size in
the dichotomous analysis to result in detection of a higher
percentage of the significant differences from continuous analysis.
Similarly, increasing sample size in the dichotomous analysis also
resulted in a decrease in the percentage of genes seen to be
significant in the dichotomous analysis but not the continuous
analysis. Since we were interested in determining efficiency of
dichotomous analysis approaches in capturing the continuous
effects of HTT CAG repeat lengths on gene expression, we
constructed regression models based on the simulation analysis
(Fig. 5; red lines). Then we estimated the number of samples that
would be required to achieve two arbitrarily selected performance
criteria for the dichotomous analysis: 1) identification of 80% of
the significant differences detected in continuous analysis and, 2) a
yield of only 20% of differences predicted as significant that are
actually non-significant by continuous analysis. By extrapolating
models, we estimated that approximately 133 and 206 samples in
each group would be required to achieve these respective limits,
indicating that analysis in a dichotomous fashion requires
significantly more samples than continuous analysis to capture
the CAG-length correlated effects of the HTT repeat on gene
expression (Fig. 5). Taken together, these results reveal potential
limitations of dichotomous analytical approaches in studying the
effects of a mutation/polymorphism with a continuum of lengths,
reinforcing the importance of the use of appropriate analytical
approaches in HD and potentially in other of the growing number
of triplet repeat expansion disorders.
Finally, we created a searchable website (HD CAGnome) to
encourage the application of continuous analysis approaches in
HD by presenting correlation analysis results from our microarray
gene expression data analysis. The web interface (Fig. 6) supports
two options: 1) entering a human gene symbol in the search
window or 2) browsing a list of genes. Selecting a gene using the
search window and browse function retrieves identical informa-
HD CAGnome
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Figure 1. Overall characteristics of continuous and dichotomous analysis results. Pearson’s correlation test was performed for continuous
analysis. The distribution of correlation coefficient (A) and correlation coefficient vs. significance (i.e., 2log10(p-value)) (B) were plotted. For
dichotomous analysis, Student’s-t test was used, and the distribution of fold-changes (C) and fold-change vs. significance (2log10(p-value)) (D) were
plotted.
doi:10.1371/journal.pone.0095556.g001
Figure 2. Quantile-quantile plot. Expected p-values assuming a uniform distribution (X-axis; expected 2log10(p-value)) were compared to
observed p-values (Y-axis; observed2log10(p-value)) in the continuous analysis (A) and dichotomous analysis (B) to evaluate the levels of inflation in
test statistics. Expected p-values were calculated based on the uniform distribution assuming each test was independent of others.
doi:10.1371/journal.pone.0095556.g002
HD CAGnome
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tion. The link to the HUGO Gene Nomenclature Committee
(HGNC) is provided as a resource for obtaining the symbol of a
gene of interest. The search results in HD CAGnome will show the
full gene names, official gene symbols, Entrez IDs, and Affymetrix
probe IDs. Primarily, HD CAGnome was designed to provide
information concerning the correlation structure between gene
expression levels and HTT CAG repeat length. The results (scatter
plot) of the summary statistics from continuous analyses (Pearson’s
correlation analysis and Spearman’s correlation analysis) are
presented in the left side of the window. A box plot with summary
statistics of dichotomous analysis (Student’s t-test) is also presented
in the right side of window. HD CAGnome is freely available for
online searching and downloading at http://chgr.partners.org/
cagnome.cgi.
Discussion
The strong negative correlation between age at onset of HD
motor symptoms and HTT CAG repeat size supports a role for
CAG length-dependent continuous mechanisms in determining
Figure 3. Comparison of test statistics. (A) Pearson’s correlation coefficients in the continuous analysis were compared to fold-changes in the
dichotomous analysis to evaluate overall similarity in direction of changes between two analytical methods. The number in each quadrant represents
the percentage of probes relative to all probes analyzed. (B) Significance levels in the continuous analysis (2log10(Pearson’s test p-value); X-axis)
were compared to those in the dichotomous analysis (2log10(Student’s t-test p-value); Y-axis) in order to evaluate overall similarity in significance
between two analytical methods.
doi:10.1371/journal.pone.0095556.g003
Figure 4. Significant probes in continuous and dichotomous analysis. Pearson’s correlation test and Student’s-t test were used for
continuous and dichotomous analysis, respectively. (A) From left to right, numbers in Venn diagram indicate the number of probes significant only in
continuous analysis, probes significant in both continuous and dichotomous analysis, and probes significant only in dichotomous analysis by p-value
cut-off of 0.01. We did not observe differences between shared genes and specific genes in terms of p-values, correlation coefficients, and fold-
changes. (B) Probes significant in both analyses (154 probes) were further categorized based on the correlation coefficient and fold-change.
doi:10.1371/journal.pone.0095556.g004
HD CAGnome
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the rate of the underlying disease process in HD. However,
dichotomous analysis comparing HD versus normal controls is a
standard in the field, where differences in the HTT CAG repeat
length between expanded alleles are rarely taken into account
[12,13,14,15,16,17,18]. Based upon the knowledge that the rate-
determining processes in pathogenesis leading to diagnostic onset
are dependent on the HTT CAG repeat length, we predicted that
dichotomous analytical methods have a lower sensitivity in
identifying important biological changes that are relevant to HD
compared to continuous analytical methods. To test this predic-
tion, we compared a set of HTT CAG repeat length-correlated
genes to differentially expressed genes, and observed a minimal
overlap between nominally significant genes in continuous and
dichotomous analysis. As the HTT CAG repeat length-correlated
genes fulfill the genetic criteria for being associated with the
pathogenic process in HD, these findings suggested that dichot-
omous analysis likely generates results with significant false
negatives and false positives that could confound further investi-
gation. In addition, sample size directly influenced the levels of
such false negative and false positive metrics in the dichotomous
analysis, i.e., an increase of sample size by 10 (10 HD and 10
controls) had the effect of decreasing the corresponding metrics by
Figure 5. Efficiency of dichotomous analysis in capturing significantly correlated genes. From 107 samples, we randomly selected equal
numbers (n = 3 to 41) of HD and controls to perform dichotomous analysis, repeating 1,000 times for each sample size, and compared to continuous
CAG length analysis, as described in the text and methods, plotting the resulting percentages in scatter density plots. (A) Variation in the percentage
of CAG-length correlated significant differences from continuous analysis that are detected by dichotomous analysis vs. sample size. (B) Variation in
the percentage of differences judged significant by dichotomous analysis that are not CAG-length correlated by continuous analysis vs. sample size.
Red lines represent linear regression models describing the relationship between sample size and the corresponding performance metric.
doi:10.1371/journal.pone.0095556.g005
Figure 6. HD CAGnome. HD CAGnome is accessible at http://chgr.partners.org/cgi-bin/cagnome.cgi.
doi:10.1371/journal.pone.0095556.g006
HD CAGnome
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6% and 4%, respectively. These observations imply that dichot-
omous analysis of HD will reveal HTT CAG repeat length-
dependent changes only with significantly larger sample sizes.
Gene expression can be influenced by many factors, both
genetic and environmental. We recently showed using a contin-
uous analysis of microarray gene expression data that ,20% of
variance in gene expression could be attributed to HTT CAG
repeat length [9]. Together with the relative performance of
dichotomous analysis in these experiments, the modest size of this
CAG length effect suggests that most of the differences significant
by dichotomous analysis are ‘noise’. Pathway analysis, gene set
enrichment analysis, and network analysis are popular in the field
because the power and sensitivity would be increased if properly
performed based on correct and unbiased gene level analysis
results. However, we predict that such limitations of dichotomous
analytical methods may result in elevated inaccuracy when
genome-wide scale large data are analyzed by this approach since
the inherent high rate of false positives would be compounded in
subsequent pathway and molecular network analyses, reducing
their reliability. Understanding how cells modulate the expression
of genes in response to the expanded HTT CAG repeats is
important as this can provide insights into underlying mechanisms
and pathways of HD. In addition, genes with altered levels of
expression are of great utility as HD biomarkers. As we described
previously, the HTT CAG repeat length has a modest impact on
the gene expression [9], indicating that analysis with insufficient
power may generate significant numbers of false negatives. In
addition, highly heterogeneous nature of human subjects poses a
challenge to the discovery of genes whose expression levels are
altered in blood and brains of HD subjects [12,13,17]. In this
context, the use of CAG repeat length as a continuous variable
may reduce false discoveries because influences of confounding
factors on statistical models would be reduced in a continuous
analysis.
In summary, our analysis reveals that there are potential
limitations in using dichotomous analysis approaches when
studying HD, especially when the number of samples may be
constrained by the availability of a given tissue or cell type.
Knowledge from direct comparisons between continuous and
dichotomous analysis results is important as this will provide
guidelines for molecular studies aiming at investigating the HTT
CAG repeat length-dependent changes, for example in choosing
samples that represent a full-spectrum of CAG repeat lengths.
Motivated by these findings, we created a website, namely ‘HD
CAGnome’ that can be used to examine the strength and direction
of correlation between HTT CAG repeat length and expression
levels of a given gene. We also provide a summary of dichotomous
analysis results so users can compare two results. We believe that
this novel resource will provide convenient ways of evaluating
correlation structure of candidate genes and generating new
hypotheses, that may be tested in other cell types, including
neuronal cells, and tissue samples, for example studies with
postmortem brain tissue. Therefore, our findings presented in HD
CAGnome will facilitate the use of analytical approaches that are
relevant to HD and contribute to identifying genes that can be
used for therapeutic treatments and/or biomarkers.
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